Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorEke, G.
dc.contributor.authorKuzmina, A. M.
dc.contributor.authorGoreva, A. V.
dc.contributor.authorShishatskaya, E. I.
dc.contributor.authorHasirci, N.
dc.contributor.authorHasirci, V.
dc.date.accessioned2019-11-24T20:38:36Z
dc.date.available2019-11-24T20:38:36Z
dc.date.issued2014
dc.identifier.issn0957-4530
dc.identifier.issn1573-4838
dc.identifier.urihttps://dx.doi.org/10.1007/s10856-014-5169-5
dc.identifier.urihttps://hdl.handle.net/20.500.12513/2550
dc.descriptionWOS: 000336904200008en_US
dc.descriptionPubMed ID: 24510225en_US
dc.description.abstractThe purpose of this study was to develop micro and nano sized drug carriers from poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV), and study the cell and skin penetration of these particles. PHBV micro/nanospheres were prepared by o/w emulsion method and were stained with a fluorescent dye, Nile Red. The particles were fractionated by centrifugation to produce different sized populations. Topography was studied by SEM and average particle size and its distribution were determined with particle sizer. Cell viability assay (MTT) was carried out using L929 fibroblastic cell line, and particle penetration into the cells were studied. Transdermal permeation of PHBV micro/nanospheres and tissue reaction were studied using a BALB/c mouse model. Skin response was evaluated histologically and amount of PHBV in skin was determined by gas chromatography-mass spectrometry. The average diameters of the PHBV micro/nanosphere batches were found to be 1.9 mu m, 426 and 166 nm. Polydispersity indices showed that the size distribution of micro sized particles was broader than the smaller ones. In vitro studies showed that the cells had a normal growth trend. MTT showed no signs of particle toxicity. The 426 and 166 nm sized PHBV spheres were seen to penetrate the cell membrane. The histological sections revealed no adverse effects. In view of this data nano and micro sized PHBV particles appeared to have potential to serve as topical and transdermal drug delivery carriers for use on aged or damaged skin or in cases of skin diseases such as psoriasis, and may even be used in gene transfer to cells.en_US
dc.description.sponsorshipGovernment of the Russian Federation [220, 11.G34.31.0013, MD-3112.2012.4]; EC FP7 SKINTREAT project; State Planning Organization (Turkey)Turkiye Cumhuriyeti Kalkinma Bakanligien_US
dc.description.sponsorshipThe study was supported by the Government of the Russian Federation (Decree No. 220 of 09.04.2010) (Agreement No. 11.G34.31.0013) and (Grant No MD-3112.2012.4). We gratefully acknowledge the EC FP7 SKINTREAT project and the State Planning Organization (Turkey) for the grant to establish BIOMATEN. Mr. A. Buyuksungur is acknowledged for his contributions with CLSM.en_US
dc.language.isoengen_US
dc.publisherSPRINGERen_US
dc.relation.isversionof10.1007/s10856-014-5169-5en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleIn vitro and transdermal penetration of PHBV micro/nanoparticlesen_US
dc.typearticleen_US
dc.relation.journalJOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINEen_US
dc.contributor.departmentKırşehir Ahi Evran Üniversitesi, Fen-Edebiyat Fakültesi, Kimya Bölümüen_US
dc.identifier.volume25en_US
dc.identifier.issue6en_US
dc.identifier.startpage1471en_US
dc.identifier.endpage1481en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster